TCWP’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,820
Closed -$712K 70
2023
Q3
$712K Buy
5,820
+122
+2% +$15.5K 0.54% 51
2023
Q2
$723K Buy
5,698
+166
+3% +$21.6K 0.15% 96
2023
Q1
$715K Buy
+5,532
New +$724K 0.14% 119
2022
Q2
Sell
-1,534
Closed -$199K 939
2022
Q1
$199K Sell
1,534
-4,640
-75% -$604K 0.04% 268
2021
Q4
$942K Buy
+6,174
New +$956K 0.19% 106

Other funds holding IBB

TCWP's IBB Position: Q4 2023 in Review

TCWP sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 5,820 shares — an estimated $712K sold.

TCWP first reported a position in IBB in Q4 2021 and held it in 5 quarters. The position peaked at $942K in Q4 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • TCWP reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • TCWP sold 5,820 iShares Biotechnology ETF shares in Q4 2023, an estimated $712K.
  • TCWP first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 5 quarters.
  • TCWP's iShares Biotechnology ETF position peaked at $942K in Q4 2021.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on TCWP's 13F filing for Q4 2023, filed 14 Feb 2024.